Profil
Ji-Hoon Sohn is currently the Chief Executive Officer & Director at PharmaResearch Co., Ltd. since 2025 and a Director at Hugel, Inc. since 2018.
Formerly, Mr. Sohn was President, Co-Chief Executive Officer & Director at DONG WHA PHARM Co., Ltd. Education includes an MBA from Boston University conferred in 1988 and an undergraduate degree from Korea University.
Postes actifs de Ji-Hoon Sohn
| Sociétés | Poste | Début |
|---|---|---|
| HUGEL, INC. | Directeur/Membre du Conseil | 26/06/2018 |
| PHARMARESEARCH CO., LTD. | Directeur Général | 25/03/2025 |
Anciens postes connus de Ji-Hoon Sohn
| Sociétés | Poste | Fin |
|---|---|---|
| DONGWHA PHARM.CO.,LTD | Directeur Général | - |
Formation de Ji-Hoon Sohn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
DONG WHA PHARM Co., Ltd.
DONG WHA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicinal chemicals | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hugel, Inc.
Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
PharmaResearch Co., Ltd.
PharmaResearch Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology | Health Technology |
















